Datatrak International, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 05, 2020 at 02:44 pm EDT
Share
DATATRAK International, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was USD 1.745 million compared to USD 1.883 million a year ago. Operating loss was USD 38,457 compared to operating Income of USD 28,387 a year ago. Net loss was USD 40,672 compared to net income of USD 30,341 a year ago. Basic loss per share was USD 0.02 compared to basic earnings per share of USD 0.01 a year ago. For the half year, sales was USD 3.696 million compared to USD 3.805 million a year ago. Operating income was USD 23,296 compared to USD 193,060 a year ago. Net income was USD 24,868 compared to USD 196,742 a year ago. Basic earnings per share was USD 0.01 compared to USD 0.08 a year ago.
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Companyâs CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.
DATATRAK INTERNATIONAL, INC. 
